Notes / Company

Granules India Ltd.

GRANULES BSE 532482 ISIN INE101D01020 Pharmaceuticals

Fundamentals

Market cap: ₹19,670 cr
P/E: 33.06×
ROE: 13.50%
Debt / equity: 0.35
Div yield: 0.22%
52-week range: 432.60 — 804.30

The timeline — 1 note on Granules India Ltd.

June 2026

03 Jun 26 · 11:49 AM IST Brief

Brief · Mid cap

Granules India's US unit gets FDA inspection report with four open observations

The Chantilly, Virginia plant closed its FDA review with a Voluntary Action Indicated classification, but four observations remain open for resolution.

Verify on exchange BSE filings for GRANULES NSE filings for GRANULES